Personalis at IO Combinations 360°: June 20-21, 2019
Erin Newburn, MS, PhD
Associate Director, Field Application Scientist
Thursday, June 20 | TBA
Maximizing immunotherapy biomarker discovery with a multidimensional tumor immunogenomics platform
More accurate, predictive biomarker analysis may assist in the selection of effective combinatorial immunotherapy treatments for patients. Additionally, the complexity of both the tumor and tumor microenvironment suggests a comprehensive approach is needed for robust characterization of the cancer ecosystem. The ImmunoID NeXTTM platform investigates key aspects of immuno-oncology; from elucidating mechanisms of tumor escape and detecting neoantigens, to identifying novel biomarker signatures and characterizing the immune repertoire. This presentation will focus on the current challenges facing investigators in immuno-oncological translational research including maximizing data generation from a single sample and the analysis of complex data.